Table 1 Sociodemographic, clinical, and laboratory data for individuals included in the study categorized according to the presence (Group 1 + Group 3) or absence (Group 2 + Group 4) of TB
Features | Overall N = 162 | With TB (G1 + G3) N = 112 | Without TB (G2 + G4) N = 50 | P-valuea |
|---|---|---|---|---|
Gender; n (%) | ||||
 Female | 49 (30.2) | 26 (23.21) | 23 (46) | 0.005 |
 Male | 113 (69.8) | 86 (76.79) | 27 (54) |  |
Skin Colorb; n (%) | ||||
 Black | 32 (19.8) | 25 (22.32) | 7 (14) | 0.379 |
 Brown | 64 (39.5) | 41 (36.61) | 23 (46) |  |
 White | 66 (40.7) | 46 (41.07) | 20 (40) |  |
Educationc; n (%) | ||||
 Bachelor | 13 (8) | 6 (5.36) | 7 (14) | <0.001 |
 Upper-secondary | 49 (30.2) | 27 (24.11) | 22 (44) |  |
 Lower-secondary | 67 (41.4) | 46 (41.07) | 21 (42) |  |
 Primary | 26 (16) | 26 (23.21) | 0 (0) |  |
 Unknown | 7 (4.3) | 7 (6.25) | 0 (0) |  |
HIV status; n (%) | ||||
 Negative | 50 (30.9) | 24 (21.43) | 26 (52) | 0.0002 |
 Positive | 112 (69.1) | 88 (78.57) | 24 (48) |  |
CD4 count (cell/μL) (IQR) | 153 (654.25) | 130.5 (116.51) | 674 (1348) | 0.003 |
 (≤50); n (%) | 40 (25.3) | 28 (25) | 12 (24) | 0.846 |
 (>50); n (%) | 118 (74.7) | 80 (71.43) | 38 (76) |  |
CD8 (IQR) | 588 (562) | 591 (527.7) | 564 (1.128) | Â |
 (≤500); n (%) | 65 (42.5) | 44 (39.28) | 21 (42) | 1 |
 (>500); n (%) | 88 (57.5) | 59 (52.68) | 29 (58) |  |
CD4/CD8 (IQR) | 0.29 (0.96) | 0.2 (0.18) | 0.69 (1.38) | 0.004 |
 (≤1); n (%) | 111 (72.5) | 85 (75.89) | 26 (52) | 0.0002 |
 (>1); n (%) | 42 (27.5) | 18 (16.07) | 24 (48) |  |